Pancreatic Islet Cell Crosstalk: Insight Into α-/β-Cell Compensatory Mechanisms. [PDF]
Benáková Š +5 more
europepmc +1 more source
ABSTRACT Metabolic dysfunction‐associated steatotic liver disease (MASLD) has emerged as the most prevalent chronic liver disease worldwide, closely linked to the global rising incidence of obesity and metabolic syndrome. This review synthesizes current evidence on the pathogenesis, gut–liver axis, and multidisciplinary management of MASLD within the ...
Beom Kyung Kim
wiley +1 more source
Metabolic Dysfunction-Associated Steatotic Liver Disease and Incretin Receptor Agonists: A Metabolic Approach to Halting Liver Disease Progression. [PDF]
Abenavoli L +6 more
europepmc +1 more source
Glucagon receptor family in GtoPdb v.2025.3
The glucagon family of receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on the Glucagon receptor family [170]) are activated by the endogenous peptide (27-44 aa) hormones glucagon, glucagon-like peptide 1, glucagon-like peptide 2, glucose ...
Miller, Laurence J. +9 more
core +1 more source
Alpha-cell glucagon is essential for maintaining β-cell function and identity in adult mice. [PDF]
Prasadan K +15 more
europepmc +1 more source
Recent advances in incretin biology and therapeutics: From glucose-dependent insulinotropic polypeptide reappraisal to next-generation agonists. [PDF]
Kubota S, Seino Y, Yabe D.
europepmc +1 more source
Hypothalamus-liver talks: whispers in the language of metabolism. [PDF]
Ferreira V +5 more
europepmc +1 more source
Glucagon receptor signalling – backwards and forwards [PDF]
Tongzhi, Wu +4 more
openaire +2 more sources
Rat pancreatic alpha- and beta-cells are critically dependent on hormonal signals generating cyclic AMP (cAMP) as a synergistic messenger for nutrient-induced hormone release, Several peptides of the glucagon-secretin family have been proposed as ...
Thorens, B +9 more
core
High‐Fat Diet Exacerbates Neuropathology in a Transgenic Mouse Model of Multiple System Atrophy
Abstract Background Multiple system atrophy (MSA) is a rare and devastating neurodegenerative disorder. Accumulating clinical and preclinical evidence suggests that diabetes and insulin resistance may adversely influence MSA pathophysiology. Objective We investigated the potential association between diabetes, impaired glucose homeostasis, and MSA ...
Marie‐Laure Arotcarena +7 more
wiley +1 more source

